首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
【24h】

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease

机译:早期类风湿性关节炎的CD4 T细胞基因签名涉及白介素6介导的STAT3信号,特别是在抗瓜氨酸肽抗体阴性疾病中

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: We sought clinically relevant predictive biomarkers present in CD4 T-cells, or in serum, that identified those patients with undifferentiated arthritis (UA) who subsequently develop rheumatoid arthritis (RA). Methods: Total RNA was isolated from highly purified peripheral blood CD4 T cells of 173 early arthritis clinic patients. Paired serum samples were also stored. Microarray analysis of RNA samples was performed and differential transcript expression among 111 'training cohort' patients confirmed using real-time quantitative PCR. Machine learning approaches tested the utility of a classification model among an independent validation cohort presenting with UA (62 patients). Cytokine measurements were performed using a highly sensitive electrochemiluminescence detection system. Results: A 12-gene transcriptional 'signature' identified RA patients in the training cohort and predicted the subsequent development of RA among UA patients in the validation cohort (sensitivity 68%, specificity 70%). STAT3-inducible genes were over-represented in the signature, particularly in anti-citrullinated peptide antibody-negative disease, providing a risk metric of similar predictive value to the Leiden score in seronegative UA (sensitivity 85%, specificity 75%). Baseline levels of serum interleukin 6 (IL-6) (which signals via STAT3) were highest in anti-citrullinated peptide antibodies-negative RA and distinguished this subgroup from non-RA inflammatory synovitis (corrected p<0.05). Paired serum IL-6 measurements correlated strongly with STAT3-inducible gene expression. Conclusion: The authors have identified IL-6-mediated STAT-3 signalling in CD4 T cells during the earliest clinical phase of RA, which is most prominent in seronegative disease. While highlighting potential biomarker(s) for early RA, the role of this pathway in disease pathogenesis awaits clarification.
机译:目的:我们寻找存在于CD4 T细胞或血清中的临床相关预测生物标志物,以鉴定那些未分化关节炎(UA)并随后发展为类风湿关节炎(RA)的患者。方法:从173例早期关节炎临床患者的高纯度外周血CD4 T细胞中分离总RNA。配对的血清样品也被保存。进行了RNA样品的微阵列分析,并使用实时定量PCR确认了111名“训练队列”患者的差异转录表达。机器学习方法在UA的独立验证队列(62名患者)中测试了分类模型的效用。使用高度灵敏的化学发光检测系统进行细胞因子的测量。结果:12个基因的转录“签名”在训练队列中识别出RA患者,并在验证队列中预测了UA患者中RA的后续发展(敏感性68%,特异性70%)。 STAT3诱导基因在签名中过分代表,特别是在抗瓜氨酸肽抗体阴性疾病中,提供了与血清UA的莱顿评分相似的预测价值的风险度量(敏感性85%,特异性75%)。血清白细胞介素6(IL-6)(通过STAT3发出信号)的基线水平在抗瓜氨酸肽抗体阴性的RA中最高,并将该亚组与非RA炎性滑膜炎区分开(校正后的p <0.05)。配对的血清IL-6测量值与STAT3诱导型基因表达高度相关。结论:作者已经在RA的最早临床阶段就鉴定了CD4 T细胞中IL-6介导的STAT-3信号传导,这在血清阴性疾病中最为突出。在强调早期RA的潜在生物标志物的同时,该途径在疾病发病机理中的作用尚待阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号